Roanoke Asset Management’s Edwards Lifesciences EW Stock Holding History

Roanoke Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,060	Closed	-$228K	–	102
2022 Q4	$228K	Hold	3,060	–	–	0.1%	98
2022 Q3	$253K	Hold	3,060	–	–	0.12%	95
2022 Q2	$291K	Hold	3,060	–	–	0.13%	92
2022 Q1	$360K	Hold	3,060	–	–	0.13%	93
2021 Q4	$396K	Hold	3,060	–	–	0.13%	88
2021 Q3	$346K	Hold	3,060	–	–	0.12%	87
2021 Q2	$317K	Hold	3,060	–	–	0.11%	90
2021 Q1	$256K	Buy	+3,060	New	+$259K	0.11%	91
2020 Q1	–	Sell	-3,600	Closed	-$280K	–	95
2019 Q4	$280K	Hold	3,600	–	–	0.14%	84
2019 Q3	$264K	Hold	3,600	–	–	0.12%	88
2019 Q2	$222K	Hold	3,600	–	–	0.1%	95
2019 Q1	$230K	Buy	+3,600	New	+$205K	0.11%	92
2018 Q4	–	Sell	-3,600	Closed	-$209K	–	105
2018 Q3	$209K	Buy	+3,600	New	+$176K	0.09%	99

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Roanoke Asset Management's EW Position: Q1 2023 in Review

Roanoke Asset Management sold out of Edwards Lifesciences (EW) in Q1 2023, closing a stake of 3,060 shares — an estimated $228K sold.

Roanoke Asset Management first reported a position in EW in Q3 2018 and held it in 13 quarters. The position peaked at $396K in Q4 2021. 1,245 funds tracked by Wall St. Rank hold EW as of Q1 2023.

Roanoke Asset Management reported no remaining Edwards Lifesciences position as of Q1 2023 after selling out during the quarter.
Roanoke Asset Management sold 3,060 Edwards Lifesciences shares in Q1 2023, an estimated $228K.
Roanoke Asset Management first reported a position in Edwards Lifesciences in Q3 2018 and held it in 13 quarters.
Roanoke Asset Management's Edwards Lifesciences position peaked at $396K in Q4 2021.
1,245 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2023.

Based on Roanoke Asset Management's 13F filing for Q1 2023, filed 2 May 2023.